Related Experiment Video
Updated: Jul 9, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Monotherapy clinical trial design
1Epilepsy Program, Jersey Shore Medical Center, Neptune, New Jersey 07754, USA. drsachdeo@gmail.com
Neurology
|December 18, 2007
Summary
Monotherapy is preferred for epilepsy treatment, but new antiepileptic drugs (AEDs) are often tested in add-on trials. Designing effective monotherapy trials for epilepsy is challenging but crucial for future drug development.
Area of Science:
- Neurology
- Clinical Pharmacology
- Pharmaceutical Science
Background:
- Monotherapy is generally preferred over polytherapy for epilepsy management due to its simplicity and reduced risk of drug interactions.
- Investigational or newer antiepileptic drugs (AEDs) are frequently evaluated as add-on therapies in patients with refractory epilepsy.
- Current add-on trial designs for AEDs may not accurately reflect their potential efficacy or safety as monotherapy, particularly in newly diagnosed patients.
Purpose of the Study:
- To address the challenges in designing and interpreting clinical trials for antiepileptic drug (AED) monotherapy.
- To evaluate the utility of different trial designs, including active-drug superiority and conversion to monotherapy trials, for assessing AED monotherapeutic efficacy.
- To highlight the need for robust clinical trial data to guide the selection of AEDs for monotherapy, especially in patients who have not responded to previous treatments.
Main Methods:
- Discussion of the ethical and interpretational difficulties associated with placebo-controlled and active-drug noninferiority monotherapy trials.
- Examination of active-drug superiority designs aimed at providing insights into monotherapeutic efficacy.
- Analysis of the 'conversion to monotherapy' trial design, including its advantages and limitations (e.g., short duration, limited assessment of long-term safety and tolerance).
Main Results:
- Large-scale trials comparing new and old AEDs in monotherapy have not demonstrated superior efficacy for newer agents.
- Newer AEDs have shown better tolerability and safety profiles compared to older medications in monotherapy settings.
- Existing trial designs, including conversion to monotherapy, have been utilized to gather sufficient data for regulatory approval of AEDs.
Conclusions:
- Appropriately designed monotherapy clinical trials are essential for evaluating the true utility of new antiepileptic drugs (AEDs).
- While newer AEDs may offer improved safety and tolerability, their superior efficacy in monotherapy has not yet been conclusively established.
- Future research should focus on developing and implementing robust monotherapy trial designs to identify effective and safe AEDs for initial epilepsy treatment.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...